{"organizations": [], "uuid": "c390a2a54770d925c458b50d2afb984c7c146dbd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/usa-justice-pfizer/drug-maker-pfizer-to-pay-23-85-mln-to-settle-claims-it-paid-kickbacks-idUSL2N1SV0XK", "country": "US", "domain_rank": 408, "title": "Drug maker Pfizer to pay $23.85 mln to settle claims it paid kickbacks", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-24T17:19:00.000+03:00", "replies_count": 0, "uuid": "c390a2a54770d925c458b50d2afb984c7c146dbd"}, "author": "", "url": "https://www.reuters.com/article/usa-justice-pfizer/drug-maker-pfizer-to-pay-23-85-mln-to-settle-claims-it-paid-kickbacks-idUSL2N1SV0XK", "ord_in_thread": 0, "title": "Drug maker Pfizer to pay $23.85 mln to settle claims it paid kickbacks", "locations": [], "entities": {"persons": [{"name": "chizu nomiyama", "sentiment": "none"}, {"name": "sarah n. lynch", "sentiment": "none"}], "locations": [{"name": "washington", "sentiment": "none"}], "organizations": [{"name": "pfizer", "sentiment": "negative"}, {"name": "medicare", "sentiment": "none"}, {"name": "u.s. justice department", "sentiment": "none"}, {"name": "department of health and human services", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 24, 2018 / 2:20 PM / Updated 16 minutes ago Drug maker Pfizer to pay $23.85 mln to settle claims it paid kickbacks Sarah N. Lynch 1 Min Read\nWASHINGTON, May 24 (Reuters) - Drug maker Pfizer will pay $23.85 million to settle civil charges that it illegally paid kickbacks by using a foundation as a “conduit” to cover co-pay costs for Medicare patients taking three of the company’s drugs, the U.S. Justice Department said Thursday.\nAs part of the settlement, the company will also enter a corporate integrity agreement with the inspector general for the Department of Health and Human Services, which will require the company to implement new compliance measures. Reporting by Sarah N. Lynch Editing by Chizu Nomiyama", "external_links": [], "published": "2018-05-24T17:19:00.000+03:00", "crawled": "2018-05-24T17:47:02.019+03:00", "highlightTitle": ""}